Showing 3,201 - 3,220 results of 5,833 for search '"MC"', query time: 0.07s Refine Results
  1. 3201

    Maximizing tuberculosis services through private provider engagement – A case study from Pakistan by Aamna Rashid, Surbhi Sheokand, Razia Fatima, Hammad Habib, Adeel Tahir, Asim Saleem, Poshan Thapa, Petra Heitkamp

    Published 2025-05-01
    “…In this paper, we present MC’s contributions as a case study to elaborate on the crucial role of private provider engagement in improving overall TB care, increasing TB notifications, and addressing the urgent need to identify people with undiagnosed TB.…”
    Get full text
    Article
  2. 3202
  3. 3203
  4. 3204

    Probiotics Fermented Bitter Melon Juice as Promising Complementary Agent for Diabetes Type 2: Study on Animal Model by Laksmi Hartajanie, S. Fatimah-Muis, K. Heri-Nugroho HS, Ign Riwanto, M. Sulchan

    Published 2020-01-01
    “…Bitter melon (Momordica charantia/MC) contains charantin that has antidiabetic properties as an α-glucosidase inhibitor and antioxidative properties. …”
    Get full text
    Article
  5. 3205
  6. 3206
  7. 3207

    Microcystins Induces Vascular Inflammation in Human Umbilical Vein Endothelial Cells via Activation of NF-κB by Jun Shi, Jie Zhou, Min Zhang

    Published 2015-01-01
    “…However, direct molecular mechanisms of MC-LR in vascular endothelial cells (ECs) have not been understood yet. …”
    Get full text
    Article
  8. 3208

    Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy by James C. L. Chow

    Published 2025-01-01
    “…Monte Carlo (MC) simulations have become important in advancing nanoparticle (NP)-based applications for cancer imaging and therapy. …”
    Get full text
    Article
  9. 3209

    TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets by Trudy Straetemans, Mandy van Brakel, Sabine van Steenbergen, Marieke Broertjes, Joost Drexhage, Joost Hegmans, Bart N. Lambrecht, Cor Lamers, Pierre van Der Bruggen, Pierre G. Coulie, Reno Debets

    Published 2012-01-01
    “…Candidate epitopes that meet these criteria are MAGE-C2336-344/HLA-A2 (MC2/A2) and MAGE-A3243-258/HLA-DP4 (MA3/DP4). We molecularly characterized TCRαβ genes of an MC2/A2-specific CD8 and MA3/DP4-specific CD4 T-cell clone derived from melanoma patients who responded clinically to MAGE vaccination. …”
    Get full text
    Article
  10. 3210
  11. 3211
  12. 3212
  13. 3213
  14. 3214
  15. 3215
  16. 3216
  17. 3217
  18. 3218
  19. 3219

    A Comparison of Medial-congruent, Ultracongruent, and Cruciate-retaining Bearings Using a Single Cruciate-retaining Total Knee Design by Alexander V. Strait, MS, Eric J. Wilson, MD, Henry Ho, MS, Kevin B. Fricka, MD, Robert A. Sershon, MD

    Published 2025-04-01
    “…Data analyses utilized analysis of variance tests for continuous data, chi-square tests for categorical data, and Mantel-Cox tests for survivorship analysis. MC subjects were older (MC = 67.5 vs UC = 65.3 vs CR = 66.7 years; P < .001), had lower body mass index (MC = 32.4 vs UC = 33.1 vs CR = 33.2 kg/m2; P = .04), and had shorter mean follow-up (MC = 1.2 vs UC = 2.4 vs CR = 2.9 years; P < .001). …”
    Get full text
    Article
  20. 3220